Santen Pharmaceutical Co., Ltd.
35
2
2
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 35 trials
100.0%
+13.5% vs industry average
51%
18 trials in Phase 3/4
32%
9 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
A Pharmacokinetics (PK) Study in Healthy Adults
Role: lead
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Role: lead
A Study in Chinese Patients With Acquired Blepharoptosis
Role: lead
A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension
Role: lead
A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT
Role: lead
A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Role: lead
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers
Role: lead
Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia
Role: collaborator
A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension
Role: lead
The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
Role: collaborator
The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
Role: collaborator
Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime
Role: collaborator
A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE)
Role: lead
Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
Role: collaborator
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
Role: lead
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
Role: lead
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-
Role: lead
A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study
Role: lead
A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study
Role: lead
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
Role: lead